Frost & Sullivan

AUGUST 6, 2023

San Antonio, TX — 7 th Aug, 2023 — Frost & Sullivan recently researched the Asia-Pacific biotechnology contract research organization industry and, based on its findings, recognizes Avance Clinical with the 2023 Customer Value Leadership Award. In addition, the attractive 43.5%

Biotechnology 52

Biotechnology Biotech Contract research organization Biopharmaceuticals 52

LaVoie Health Science Blog

JANUARY 30, 2023

Here are the five key takeaways of the conference and what to expect as we come to the end the first month of the year: Biotech is Back: The COVID-19 pandemic caused a downturn for the biotech sector as whole, but JP Morgan Week showed a strong turnout, proving interest in both the science and investor sides of the industry.

Biotech 98

Biotech Biotechnology Finance Data partnerships 98

Frost & Sullivan

MARCH 28, 2025

The pharmaceutical and biotechnology industries are at the cusp of a transformative era in 2025, driven by cutting-edge innovation, evolving regulations, and increasing market pressures. Download our full analysis on the top 6 growth opportunities in pharma and biotech. Want deeper insights? billion in sales.

Biotech 52

Biotech Biotechnology Strategic partnership Insurance 52

Frost & Sullivan

MARCH 28, 2025

Elabscience Biotechnology, Inc., Quanterix, Response Biomedical Corp., Tosoh Bioscience, Tulip Diagnostics Pvt. Notable Mergers & Acquisitions Roches acquisition of LumiraDxs POC business will enhance its POC capabilities and market presence.

Biotechnology 52

Biotechnology Biotech Ecosystems 52

Frost & Sullivan

JANUARY 23, 2025

The 43rd JP Morgan Healthcare Conference , held from January 1316, 2025, in San Francisco, brought together a vibrant ecosystem of global pharma stakeholders, innovative startups, emerging biotech companies, and investors.

Biotechnology 52

Biotechnology Mergers and acquisition activities Biotech Biopharma 52